Since there are presently no recognized and accepted biomarkers for assessing SCI levels alone, SCI is usually measured by combining the clinical biomarkers of acute inflammation and infection, such as CRP, IL-6, and TNF-α [27]. This evidence concerns the gene IL6 and infection.